Zarxio (filgrastim-sndz)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
WARNINGS AND PRECAUTIONS
Glomerulonephritis
Glomerulonephritis has occurred in patients receiving filgrastim...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts